GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » Gross Profit

Lophos Holdings (XCNQ:MESC) Gross Profit : C$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Lophos Holdings Gross Profit?

Lophos Holdings's gross profit for the three months ended in Mar. 2024 was C$0.00 Mil. Lophos Holdings's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Lophos Holdings's gross profit for the three months ended in Mar. 2024 was C$0.00 Mil. Lophos Holdings's Revenue for the three months ended in Mar. 2024 was C$0.00 Mil. Therefore, Lophos Holdings's Gross Margin % for the quarter that ended in Mar. 2024 was N/A%.

Lophos Holdings had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Lophos Holdings Gross Profit Historical Data

The historical data trend for Lophos Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lophos Holdings Gross Profit Chart

Lophos Holdings Annual Data
Trend Mar22 Mar23 Mar24
Gross Profit
- - -

Lophos Holdings Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Lophos Holdings's Gross Profit

For the Biotechnology subindustry, Lophos Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lophos Holdings's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lophos Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Lophos Holdings's Gross Profit falls into.



Lophos Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Lophos Holdings's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Lophos Holdings's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Lophos Holdings's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Lophos Holdings  (XCNQ:MESC) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lophos Holdings had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Lophos Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of Lophos Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Lophos Holdings Business Description

Traded in Other Exchanges
N/A
Address
1111 Melville Street, Suite 620, Vancouver, BC, CAN, V6E 3V6
Website
Lophos Holdings Inc is engaged in the y is the cultivation of peyote and the manufacture of Lophophora compounds, including Mescaline, as well as formulation of novel Lophophora-based compounds.
Executives
John Ioannis Karagiannidis Director
Evan Stawnyczy Director

Lophos Holdings Headlines

No Headlines